A U.S. chipmaking powerhouse's stock soared 8 percent after quarterly profits turned positive, defying prior losses.
Q3 beats stemmed from cost controls, lifting YTD gains to 90 percent amid $92 billion capex.
Analysts raise targets to $30, citing turnaround momentum in $500 billion sector.
Strategic partners eye synergies, with options trades signaling $21 floors.
Pessimistic outlooks persist on margins, but $25 targets loom plausible.
The swing reflects R&D yields, with $30 billion spends bearing fruit.
Investor sales of 18,000 shares hint profit-taking, yet underweight ratings hold.
This rebound validates $150 million quarterly investments.
Economic ties link chips to $1 trillion AI booms.
The stock's arc mirrors recovery plays in volatile markets.
